Trial
NCT02935543
CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Leukemia, Acute Lymphoblastic
Intervention
CART 19
Why stopped
Study is terminated because of administrative reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-22